The two complications, which appear to be unrelated, also appear to be unrelated to clinician experience.
“Unclear how much of the increase in child cases is due to increased testing capacity,” AAP says.
Requests to a telemedicine service for self-managed abortion care increased in the wake of COVID-19 clinic shutdowns.
But physicians are adapting and still finding joy in treating patients.
New guideline articulates a broad approach to treatment that needs to be tailored to individual patients.
Atezolizumab may improve survival when it’s added to nab-paclitaxel but not paclitaxel, studies suggest.
A post hoc analysis linked greater blood-glucose time in range with fewer hypoglycemic, microvascular, and major adverse cardiac events in T2D patients.
Results of two new studies provide further evidence that exercise reduces all-cause and cardiovascular mortality in those with type 2 diabetes.
Simulation study supports value of mifepristone and misoprostol for medical management of miscarriage.
New therapies for this common and challenging condition may be on the horizon.
Three agents that address major unmet needs move to phase 3.
“Enhanced responsiveness to food cues may be a mediating mechanism underlying overeating in ADHD,” said Elizabeth Martin, MSc.
Data suggest fewer people are dying from stomach cancer, but in some countries, the risk of colorectal cancer death is increasing or declining much more slowly than other causes of premature death.
A systematic review provides limited evidence to support oral beta-blockers as a treatment for rosacea-associated facial erythema and flushing.
"While benzodiazepines are important therapies for many Americans, they are also commonly abused and misused," said Commissioner Stephen M. Hahn, MD.
Until now, SGLT2 inhibitors were for patients with an eGFR of at least 30 mL/min per m2. New evidence moves the threshold down to 25.
Registry data revealed factors associated with intraoperative and postoperative complications.
The proportion of chats handled at the crisis hotline was 48% greater in the first half of 2020, compared with a year earlier.
Adverse effects – particularly frequency of infection – were increased in the high-dose group.
Rare but serious and possibly life-threatening autoimmune events that have recently been linked to the drug.
Dr. Marcy B. Bolster addresses common patient concerns about bisphosphonate use.
A higher percentage of total B cells, and in particular plasmablasts, could be a very predictive biomarker for autoimmunity after alemtuzumab treatment.
“We will always observe standard precautions, which include hand hygiene, gloves, hair and eye cover, medical mask, and face shield,” Dr. Charles Griffis said.